# Clinical Study of Adipose Derived Mesenchymal Stem Cells for Treatment of Pulmonary Arterial Hypertension

> **NCT04055415** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Liaocheng People's Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **BIOLOGICAL:** adipose derived mesenchymal stem cells
- **DRUG:** Conventional drug therapy（expectorant，bronchodilator）

## Key facts

- **NCT ID:** NCT04055415
- **Lead sponsor:** Liaocheng People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-01
- **Primary completion:** 2020-08-01
- **Final completion:** 2021-02-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04055415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04055415, "Clinical Study of Adipose Derived Mesenchymal Stem Cells for Treatment of Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04055415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*